Dec-20-24 05:25PM Why Cytokinetics Stock Was a Nearly 5% Winner Today (Motley Fool) 12:00AM Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China (GlobeNewswire) Dec-06-24 11:31AM Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Repor...
Mean Target Price 79.30 Low Target Price 60.00 Standard Deviation: 16.55 Number of Estimates 20 Date of Most Recent Estimate 03/06/25 Created with Highcharts 5.0.7# Estimates: 205060708090100110120130 Mean 79.30 High 120.00 Low 60.00 Created with Highcharts 5.0.7Price Estimate# EstimatesHighMeanLow...
A high-level overview of Cytokinetics, Incorporated (CYTK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Goldman Sachs analyst revisits Rivian stock price target after Q4 earnings Rivian's R2 SUV, which is expected to challenge Tesla's Model Y, will launch early next year. RIVN Latest Commodity Market News Feb 20, 2025 4:37 PM EST
Bid Price and Ask Price The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest amount that a seller is currently willing to sell. ...
Some better-ranked stocks from the sector areCastle BiosciencesCSTL,BioMarin PharmaceuticalBMRNandCytomX TherapeuticsCTMX. While CSTL and BMRN currently sport a Zacks Rank #1 (Strong Buy) each, CTMX carries a Zacks Rank #2 (Buy) at present. You can seethe complete list of today’s Zacks #1...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie (ABBV – Research Report), Molina Healthcare...
Current Price $20.36 NASDAQ: AMPH Amphastar Pharmaceuticals Market Cap $1B Current Price $26.61 NYSE: BHC Bausch Health Companies Market Cap $2B Current Price $5.33 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley...
on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock pr...
11:02aBarron'sThese Stocks Are Moving the Most Today: Tesla, Rivian, DJT, CoreWeave, Nvidia, nCino, BlackBerry, and More 10:57aBarron'sIt Was a Rough Quarter for Billionaires, Too: 8 of the World’s Richest People Lost Money